Trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['lcsm,(-blcsm)', 'nsclc', 'sclc']
destiny: adc are here to stay for nsclc!! #esmo22 #lcsm
VP, Clinical Research @Gileadsciences thoracic oncologist, clinical researcher, a proud Dad. Personal account and opinions, tweets and RT are my own opinion.